(2H, br d, py, 3-CH), 5.02 (2H, m, HC CH), 2.92 [1H, br sept,
CH(CH3)2], 1.95 (4H, m, CHCH2), 1.36 (4H, m, CH2CH2CH3),
1.01 [3H, t, J(H–H) = 7.5 Hz, CHCH2CH3], 0.96 [6H, br d,
CH(CH3)2], 0.89 [3H, t, J(H–H) = 7.1 Hz, CH2CH2CH3]. 13C
NMR (298 K; CD3OD): d 157.66, 149.88, 148.38, 141.66, 140.05,
132.25, 131.76, 130.52, 129.57, 120.68, 118.94, 106.49, 104.47,
33.79, 29.53, 29.05, 23.89, 23.66, 22.61, 15.19, 14.35.
5.06 (2H, m, HC CH), 2.92 [1H, br s, CH(CH3)2], 1.96 (4H,
m, CHCH2), 1.44 [4H, sext, J(H–H) = 7.4 Hz, CH2CH3], 0.98
[6H, br s, CH(CH3)2], 0.93 [6H, t, J(H–H) = 7.4 Hz, CH2CH3].
13C NMR (298 K; CD3OD): d 157.80, 149.67, 148.42, 141.54,
140.26, 132.01, 131.75, 130.54, 129.73, 120.55, 118.73, 113.75,
36.38, 29.47, 24.96, 23.88, 14.04.
Crystallographic studies
[Cu(2-iPrC6H4-dpa)(g2-trans-3-octene)]BF4 (4)
X-ray data for compound 2 was collected at room temperature
on a Bruker SMART 1000 CCD diffractometer equipped with
This compound was prepared in an analogous manner to that
of (1), using the ligand 2-iPrC6H4-dpa and olefin trans-3-octene.
Yield: 39%. MP (TGA; decomp.) 123–125 ◦C. FTIR (neat,
ATR, cm-1): 3123 (w, aromatic nC–H), 3094 (w, aromatic nC–H),
3071 (w, aromatic nC–H), 3037 (w, alkene nC–H), 2961 (w, alkene
˚
graphite monochromated Mo-Ka radiation (l = 0.71073 A) and
a fixed-c 3-circle GGCS configuration, and corrected for Lorentz
and polarization effects. The sample was prepared by suspension
in mineral oil under an inert atmosphere (facilitating separation
and selection of a single crystal), followed by sealing in a thin
layer of epoxy resin and securing to the end of a glass fiber.
The fiber was fastened to a brass pin and mounted onto the
goniometer head. Data collection and unit cell refinement were
carried out according to established methods23 using the program
SMART.24 The program SAINT25 was used for data reduction,
and absorption correction was applied using SADABS.26 Pertinent
details are given in Table 3. The structure was solved by direct
methods, and the model was refined using full-matrix least squares
techniques.27 All non-hydrogen atoms were first refined as having
isotropic thermal parameters, followed by having anisotropic
thermal parameters: shift/error less than 0.01. Refinement of
the noncentrosymmetric structure (space group P21) was per-
formed according to established methods, using TWIN/BASF
instructions.28,29 This treatment (refinement of the structure as
having an inversion twin) refined the absolute structure with a
fractional presence, i.e. Flack ¥ parameter, of 0.45(2), with 6210
(79.9%) measured Friedel pairs. All hydrogen atoms were placed in
n
C–H), 2927 (w, alkyl nC–H), 2870 (w, alkyl nC–H), 1598 (m), 1582–
1431 (s, aromatic dC C), 1324 (s, aromatic nC–N), 1281 (w), 1242
(m), 1170 (m), 1052 (br vs, nB–F), 930 (w), 783 (m), 772 (m), 764
(m). 1H NMR (298 K; CD3OD): d 8.22 (2H, br s, py, 6-CH), 7.80
(2H, br t, py, 4-CH), 7.63 (1H, m, C6H4), 7.60 (1H, m, C6H4), 7.42
(2H, br m, C6H4), 7.18 (2H, br t, py, 5-CH), 6.78 (2H, br d, py, 3-
CH), 5.09 (2H, m, HC CH), 2.91 [1H, br sept, CH(CH3)2], 1.99
(4H, m, CHCH2), 1.36 (4H, m, CH2CH2CH3), 1.02 [3H, t, J(H–
H) = 7.3 Hz, CHCH2CH3], 0.97 [6H, br d, CH(CH3)2], 0.91 [3H,
t, J(H–H) = 7.2 Hz, CH2CH2CH3]. 13C NMR (298 K; CD3OD):
d 157.73, 149.64, 148.44, 141.54, 140.18, 132.04, 131.80, 130.55,
129.80, 120.37, 118.55, 116.59, 114.03, 33.93, 33.85, 29.45, 27.32,
23.88, 23.28, 15.31, 14.38.
[Cu(2-iPrC6H4-dpa)(g2-cis-4-octene)]BF4 (5)
This compound was prepared in an analogous manner to that of
(1), using the ligand 2-iPrC6H4-dpa and olefin cis-4-octene. Yield:
65%. MP (TGA; decomp.) 132–134 ◦C. FTIR (neat, ATR, cm-1):
3127 (w, aromatic nC–H), 3068 (w, aromatic nC–H), 2959 (m, alkyl
˚
calculated positions [C–H (alkene) = 0.98 A, C–H (methylene) =
˚
˚
˚
0.97 A, C–H (methyl) = 0.96 A, and C–H (aromatic) = 0.93 A]
and refined using a riding model with fixed isotropic displacement
parameters. Neutral-atom scattering factors were taken from the
usual source.30 Refinement of positional and anisotropic displace-
ment parameters led to convergence for all data. The program
n
C–H), 2930 (w, alkyl nC–H), 2869 (w, alkyl nC–H), 1599 (m), 1582–
1431 (s, aromatic dC C), 1327 (s, amine nC–N), 1242 (m), 1167 (w),
1057 (br vs, nB–F), 1025 (br vs), 783 (s). 1H NMR (298 K; CD3OD):
d 8.28 (2H, br s, py, 6-CH), 7.82 (2H, br t, py, 4-CH), 7.64 (1H,
m, C6H4), 7.60 (1H, m, C6H4), 7.53 (1H, br s, C6H4), 7.49 (1H,
br s, C6H4), 7.23 (2H, br t, py, 5-CH), 6.88 (2H, br d, py, 3-CH),
5.08 (2H, m, HC CH), 2.97 [1H, br s, CH(CH3)2], 1.93 (4H,
m, CHCH2), 1.42 [4H, sext, J(H–H) = 7.4 Hz, CH2CH3], 0.97
[6H, br s, CH(CH3)2], 0.92 [6H, t, J(H–H) = 7.4 Hz, CH2CH3].
13C NMR (298 K; CD3OD): d 157.40, 149.75, 148.42, 141.62,
139.92, 132.66, 131.83, 130.53, 129.53, 120.57, 118.60, 107.40,
31.46, 29.52, 24.69, 23.94, 14.35.
Table 3 Summary of X-ray diffraction data for compound 2
Empirical formula
MW
CuC27H35N3BF4
551.93
Monoclinic
P21
9.943(2)
21.275(4)
13.874(3)
107.19(3)
2804(1)
4
1.308
0.825
3.08–58.34
68486
Crystal system
Space group
˚
a/A
˚
b/A
˚
c/A
b/◦
[Cu(2-iPrC6H4-dpa)(g2-trans-4-octene)]BF4 (6)
3
˚
V/A
Z
This compound was prepared in an analogous manner to that
of (1), using the ligand 2-iPrC6H4-dpa and olefin trans-4-octene.
Yield: 59%. MP (TGA; decomp.) 124–125 ◦C. FTIR (neat,
ATR, cm-1): 3121 (w, aromatic nC–H), 3069 (w, aromatic nC–H),
2960 (m, alkyl nC–H), 2928 (w, alkyl nC–H), 2868 (w, alkyl nC–H),
1596 (m), 1580–1429 (s, aromatic dC C), 1325 (s, amine nC–N), 1243
D
calc/g cm-3
m/mm-1
2q range/◦
No. collected
No. ind. (Rint
)
13982 (0.0885)
6381
0.0937
No. obsd. (|F0| > 4.0s |F0|)
R
Rw
1
(m), 1168 (w), 1052 (br vs), 1025 (br vs, nB–F), 783 (s). H NMR
0.2139
-3
˚
Largest difference peak and hole/eA
Weights
CCDC no.
2.449, -0.624
0.0926, 0
733204
(298 K; CD3OD): d 8.18 (2H, br s, py, 6-CH), 7.81 (2H, br t,
py, 4-CH), 7.64 (1H, m, C6H4), 7.59 (1H, m, C6H4), 7.42 (2H, br
m, C6H4), 7.19 (2H, br t, py, 5-CH), 6.81 (2H, br s, py, 3-CH),
This journal is
The Royal Society of Chemistry 2011
Dalton Trans., 2011, 40, 1189–1194 | 1193
©